Atopic Dermatitis - Tacrolimus Prior Authorization Criteria – Medicare Part D
Prior Authorization Criteria for Approval
Tacrolimus ointment will be approved when ONE of the following is met:
- The patient has a diagnosis of atopic dermatitis AND ONE of the following:
- The patient has tried and had an inadequate response to a topical corticosteroid or topical corticosteroid combination preparation (e.g., hydrocortisone, triamcinolone) OR
- The patient has an intolerance or hypersensitivity to a topical corticosteroid or topical corticosteroid combination preparation OR
- The patient has an FDA labeled contraindication to a topical corticosteroid or topical corticosteroid combination preparation OR
- The patient has an indication that is supported in CMS approved compendia for the requested medication
Length of Approval: 12 months
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.